Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

Trautmann, Lydie, Janbazian, Loury, Chomont, Nicolas, Said, Elias A, Gimmig, Sylvain, Bessette, Benoit, Boulassel, Mohamed-Rachid, Delwart, Eric +5 more·2006·Nature Medicine

Cited by (1,001)

Items 901–1,000 of 1,001

  1. A Participant-Derived Xenograft Model of HIV Enables Long-Term Evaluation of Autologous Immunotherapies
    Chase D. McCann, Christiaan Hendrik van Dorp, Ali Danesh, Adam R. Ward, Thomas R. Dilling, Talia M. Mota, Elizabeth A. Zale, Eva M. Stevenson, Shabnum Patel, Chanson J. Brumme et al. · 2020 · The Journal of Experimental Medicine
  2. Programmed death 1: a critical regulator of T-cell function and a strong target for immunotherapies for chronic viral infections
    Lydie Trautmann, Elias Anthony Said, Rabih Halwani, Loury Janbazian, Nicolas Chomont, Mohamed El Far, Gaëlle Breton, Elias K. Haddad, Rafick‐Pierre Sékaly · 2007 · Current Opinion in HIV and AIDS
  3. Development of Spontaneous Anergy in Invariant Natural Killer T Cells in a Mouse Model of Dyslipidemia
    Nicole A. Braun, Yanice Mendez-Fernandez, Roman Covarrubias, Steven Anthony Porcelli, Paul B. Savage, Hideo Yagita∥, Luc Van Kaer, Amy Stasny Major · 2010 · Arteriosclerosis Thrombosis and Vascular Biology
  4. Effects of goat milk–based formula on development in weaned rats
    Meihong Xu, Liren Wei, Zhiyong Dai, Yanchun Zhang, Yong Li, Junbo Wang · 2015 · Food & Nutrition Research
  5. CD3ε Expression Defines Functionally Distinct Subsets of Vδ1 T Cells in Patients With Human Immunodeficiency Virus Infection
    Pádraic J. Dunne, Christina O. Maher, Michael Freeley, Katie Dunne, Andreea Petrasca, Judy Orikiiriza, Margaret R. Dunne, Derval Reidy, Siobhán O’Dea, Aisling Loy et al. · 2018 · Frontiers in Immunology
  6. Dominant Human CD8 T Cell Clonotypes Persist Simultaneously as Memory and Effector Cells in Memory Phase
    Cédric Touvrey, Laurent Derré, Estelle Devêvre, Patricia Corthésy, Pedro J. Romero, Nathalie Rufer, Daniel E. Speiser · 2009 · The Journal of Immunology
  7. CD4:CD8 lymphocyte ratio as a quantitative measure of immunologic health in HIV-1 infection: findings from an African cohort with prospective data
    Jianming Tang, Xuelin Li, Matt A. Price, Eduard Joachim Sanders, Omu Aggrey Anzala, Etienne Karita, Anatoli Kamali, Shabir Lakhi, Susan A Allen, Eric Hunter et al. · 2015 · Frontiers in Microbiology
  8. Oxidative Stress Induces Mitochondrial Compromise in CD4 T Cells From Chronically HCV-Infected Individuals
    Madison Schank, Juan Zhao, Ling Wang, Lam Ngoc Thao Nguyen, Dechao Cao, Xindi Dang, Sushant Khanal, Jinyu Zhang, Yi Zhang, Xiao Y. Wu et al. · 2021 · Frontiers in Immunology
  9. Differential effects of antiretroviral treatment on immunity and gut microbiome composition in people living with HIV in rural versus urban Zimbabwe
    Angela Sofia Burkhart Colorado, Alessandro Lazzaro, Charles Preston Neff, Nichole M. Nusbacher, Kathryn Boyd, Suzanne P. Fiorillo, Casey G Martin, Janet Siebert, Thomas Campbell, Margaret Ziona Borok et al. · 2024 · Microbiome
  10. The Programmed Death (PD)‐1/PD‐Ligand 1 Pathway Regulates Graft‐Versus‐Host‐Reactive CD8 T Cells After Liver Transplantation
    Marcus Schuchmann, Ralf Georg Meyer, E. Distler, Esther von Stebut, Jurgen H. E. Kuball, Elke Schnürer, Thomas Wölfel, M. Theobald, Abdo Konur, Sabrina Gregor et al. · 2008 · American Journal of Transplantation
  11. Immunologic Basis for Revaccination of HIV-Infected Children Receiving HAART
    Kaitlin Rainwater‐Lovett, William John Moss · 2010 · Future Virology
  12. HIV‐specific CD8+ T‐cell proliferation is prospectively associated with delayed disease progression
    Lyle R. McKinnon, Rupert Kaul, Joshua Kimani, Nico J. D. Nagelkerke, Charles Wachihi, Keith Raymond Fowke, Terry Blake Ball, Francis Allan Plummer · 2011 · Immunology and Cell Biology
  13. Innate IFN-γ Is Essential for Programmed Death Ligand-1–Mediated T Cell Stimulation following Listeria monocytogenes Infection
    Jared H. Rowe, James M. Ertelt, Sing Sing Way · 2012 · The Journal of Immunology
  14. Immunological Characterization of a Modified Vaccinia Virus Ankara Vector Expressing the Human Papillomavirus 16 E1 Protein
    Christelle Remy‐Ziller, Claire Germain, Anita Spindler, Chantal Hoffmann, Nathalie Silvestre, Ronald Rooke, Jean‐Yves Bonnefoy, Xavier Préville · 2013 · Clinical and Vaccine Immunology
  15. Enhanced PD-1 Expression by T Cells in Cerebrospinal Fluid Does Not Reflect Functional Exhaustion during Chronic Human Immunodeficiency Virus Type 1 Infection
    Shanmugalakshmi Sadagopal, Shelly L. Lorey, Louise D. Barnett, Deborah Sutherland, Rebecca Basham, Husamettin Erdem, Spyros A. Kalams, David W. Haas · 2009 · Journal of Virology
  16. Large Scale Purification of RNA Nanoparticles by Preparative Ultracentrifugation
    Daniel L. Jasinski, Chad T. Schwartz, Farzin Haque, Peixuan Guo · 2015 · Methods in molecular biology
  17. HIV-related Refractory Hodgkin Lymphoma: A Case Report of Complete Response to Nivolumab
    Elaine Chang, Gustavo Rivero, Niraj R. Patel, Elizabeth Y. Chiao, Syeling Lai, Kelash Bajaj, John E. Mbue, Sarvari Venkata Yellapragada · 2018 · Clinical Lymphoma Myeloma & Leukemia
  18. Phenotype, Polyfunctionality, and Antiviral Activity of in vitro Stimulated CD8+ T-Cells From HIV+ Subjects Who Initiated cART at Different Time-Points After Acute Infection
    Jimena Salido, María Julia Ruiz, César Trifone, María Inés Figueroa, María Paula Caruso, María Magdalena Gherardi, Omar Gustavo Sued, Horacio Salomón, Natalia Laufer, Yanina Ghiglione et al. · 2018 · Frontiers in Immunology
  19. Prediction of PD-L1 inhibition effects for HIV-infected individuals
    В.В. Желткова, Jordi M. Argilaguet, Cristina Peligero, Gennady Alekseevich Bocharov, Andreas Meyerhans · 2019 · PLoS Computational Biology
  20. CD32+CD4+ memory T cells are enriched for total HIV-1 DNA in tissues from humanized mice
    Philipp Adams, Virginie Fiévez, Rafaëla Schober, Mathieu Amand, Gilles Iserentant, Sofie Rutsaert, Géraldine Dessilly, Guido L. Vanham, Fanny Hedin, Antonio Cosma et al. · 2020 · iScience
  21. T cell immune discriminants of HIV reservoir size in a pediatric cohort of perinatally infected individuals
    Stefano Rinaldi, Lesley R. de Armas, Sara Domínguez‐Rodríguez, Suresh Pallikkuth, Vinh B. Dinh, Li Pan, Kathleen Gärtner, Rajendra Pahwa, Nicola Cotugno, Pablo Rojo et al. · 2021 · PLoS Pathogens
  22. Nef-mediated MHC class I down-regulation unmasks clonal differences in virus suppression by SIV-specific CD8+ T cells independent of IFN-γ and CD107a responses
    Jacob Taku Minang, Matthew T. Trivett, Lori V. Coren, Eugene V. Barsov, Michael Piatak, David E. Ott, Claes Öhlén · 2009 · Virology
  23. Upregulation of Interleukin 7 Receptor Alpha and Programmed Death 1 Marks an Epitope-Specific CD8+T-Cell Response That Disappears following Primary Epstein-Barr Virus Infection
    Delphine Sauce, Martin Larsen, Rachel J.M. Abbott, Andrew D. Hislop, Alison M. Leese, Naeem Khan, Laura Papagno, Gordon James Freeman, Alan B. Rickinson · 2009 · Journal of Virology
  24. Increased Immune Activation and Exhaustion in HIV-infected Youth
    Allison Ross Eckard, Julia Rosebush, S. Thera Lee, Mary Ann O’Riordan, Jakob G. Habib, Julie E. Daniels, Danielle E. Labbato, Monika Uribe-Leitz, Ann Chahroudi, Grace A. McComsey · 2016 · The Pediatric Infectious Disease Journal
  25. Subset- and Antigen-Specific Effects of Treg on CD8+ T Cell Responses in Chronic HIV Infection
    Maria H. Nikolova, Aurélie Wiedemann, Maria Muhtarova, Daniela Yordanova Achkova, Christine Lacabaratz, Yves Lévy · 2016 · PLoS Pathogens
  26. Programmed death-1+ T cells inhibit effector T cells at the pathological site of miliary tuberculosis
    Ashok Kumar Singh, A Mohan, Aparajit Ballav Dey, D K Mitra · 2016 · Clinical & Experimental Immunology
  27. High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer
    Yusuke Okuma, Tsunekazu Hishima, Jumpei Kashima, Sadamu Homma · 2017 · Cancer Immunology Immunotherapy
  28. HIV-Specific T Cells Generated from Naive T Cells Suppress HIV In Vitro and Recognize Wide Epitope Breadths
    Shabnum Patel, Elizabeth A. Chorvinsky, Shuroug Albihani, Carolina Colli Cruz, Richard Brad Jones, Elizabeth J. Shpall, David M. Margolis, Richard F. Ambinder, Catherine M. Bollard · 2018 · Molecular Therapy
  29. TCR Transgenic Mice: A Valuable Tool for Studying Viral Immunopathogenesis Mechanisms
    Yong‐Bin Cho, In-Gu Lee, Yong-Hyun Joo, So‐Hee Hong, Young‐Jin Seo · 2020 · International Journal of Molecular Sciences
  30. Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities
    Anna M. Timofeeva, Sergey E. Sedykh, Georgy A. Nevinsky · 2022 · Vaccines
  31. Human immunodeficiency virus and antiretroviral therapy-mediated immune cell metabolic dysregulation in children born to HIV-infected women: potential clinical implications
    Hope Mataramvura, Madeleine J. Bunders, Kerina Duri · 2023 · Frontiers in Immunology
  32. Low-level HIV-1 viremia affects T-cell activation and senescence in long-term treated adults in the INSTI era
    Violeta Lara‐Aguilar, Manuel Llamas-Adán, Oscar Brochado‐Kith, Celia Crespo‐Bermejo, Sergio Grande‐García, Sonia Arca-Lafuente, Ignacio de los Santos, C. M. C. O. PRADO, Mario Alía, Coral Sainz-Pinós et al. · 2024 · Journal of Biomedical Science
  33. Inverse association of repressor growth factor independent-1 with CD8 T cell interleukin (IL)-7 receptor α expression and limited signal transducers and activators of transcription signaling in response to IL-7 among γ-chain cytokines in HIV patients
    Anita C. Benoit, Khaled Abdkader, Danylo Sirskyj, Abdulkarim Alhetheel, Nadia Sant, Francisco Díaz‐Mitoma, Ashok Kumar, Marko Kryworuchko · 2009 · AIDS
  34. T-cell reconstitution during murine acquired immunodeficiency syndrome (MAIDS) produces neuroinflammation and mortality in animals harboring opportunistic viral brain infection
    Manohar B. Mutnal, Scott J. Schachtele, Shuxian Hu, James R. Lokensgard · 2013 · Journal of Neuroinflammation
  35. The safety of pembrolizumab in metastatic melanoma and rheumatoid arthritis
    Akshjot Puri, Jade Homsi · 2017 · Melanoma Research
  36. Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells
    Alba Ruiz, Oscar Blanch-Lombarte, Esther Jiménez‐Moyano, Dan Ouchi, Beatriz Mothe, Ruth Peña, Cristina Gálvez, Meritxell Genescà, Javier Martínez‐Picado, Philip Goulder et al. · 2019 · Frontiers in Immunology
  37. HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial
    Vincent Vieillard, Béhazine Combadière, Roland Tubiana, Odile Launay, Gilles Pialoux, Laurent Cotte, Pierre‐Marie Girard, Anne Simon, Yasmine Dudoit, Jacques Reynes et al. · 2019 · npj Vaccines
  38. Effect of the Use of Galectin-9 and Blockade of the TIM-3 Receptor in the Latent Cellular Reservoir of HIV-1
    Marta Sanz, Nadia Madrid-Elena, Sergio Serrano Villar, Alejandro Vallejo, Carolina Gutiérrez, Santiago Moreno · 2020 · Journal of Virology
  39. Immune Checkpoint Molecules and Glucose Metabolism in HIV-Induced T Cell Exhaustion
    Yee Teng Chan, Heng Choon Cheong, Ting Fang Tang, Reena Rajasuriar, Kian‐Kai Cheng, Chung Yeng Looi, Won Fen Wong, Adeeba Kamarulzaman · 2022 · Biomedicines
  40. Impact of Intrinsic Cooperative Thermodynamics of Peptide-MHC Complexes on Antiviral Activity of HIV-Specific CTL
    Chihiro Motozono, Saeko Yanaka, Kouhei Tsumoto, Masafumi Takiguchi, Takamasa Ueno · 2009 · The Journal of Immunology
  41. CD4 T-Cell Help Programs a Change in CD8 T-Cell Function Enabling Effective Long-Term Control of Murine Gammaherpesvirus 68: Role of PD-1-PD-L1 Interactions
    Peter B. Dias, Francesca Giannoni, Lian Ni Lee, Dongun Han, Sorah Yoon, Hideo Yagita∥, Miyuki Azuma, Sally R. Sarawar · 2010 · Journal of Virology
  42. The role of co-inhibitory signals in spontaneous tolerance of weakly mismatched transplants
    Govindarajan Thangavelu, KENNETH M. M. MURPHY, Hideo Yagita∥, Louis Boon, Colin C. Anderson · 2011 · Immunobiology
  43. Decreased 4-1BB expression on HIV-specific CD4+ T cells is associated with sustained viral replication and reduced IL-2 production
    Afework Kassu, Michelle D’Souza, Brian P. O’Connor, Elizabeth A. Kelly-McKnight, Ramesh Akkina, Andrew P. Fontenot, Brent E. Palmer · 2009 · Clinical Immunology
  44. Clearance of an immunosuppressive virus from the CNS coincides with immune reanimation and diversification
    Henning Lauterbach, Phi Truong, Dorian B. McGavern · 2007 · Virology Journal
  45. Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation
    Thomas Poiret, Rebecca Axelsson‐Robertson, Mats Remberger, Xiaohua Luo, Martin Rao, Anurupa Nagchowdhury, Anna von Landenberg, Ingemar T. Ernberg, Olle T.H. Ringdén, Markus J. Maeurer · 2018 · Frontiers in Immunology
  46. Editorial: PD-1, a new target for sepsis treatment: better late than never
    Sanna M. Goyert, Jack E. Silver · 2010 · Journal of Leukocyte Biology
  47. Why cure, why now?
    Daniel R. Kuritzkes · 2016 · Journal of Medical Ethics
  48. HIV cure strategies: which ones are appropriate for Africa?
    Christopher Zaab-Yen Abana, Helena Lamptey, Evelyn Yayra Bonney, George B. Kyei · 2022 · Cellular and Molecular Life Sciences
  49. Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral Therapy
    Cynthia L. Gay, Ronald J. Bosch, Ashley McKhann, Raymond Cha, Gene D. Morse, Chanelle Wimbish, Danielle M Campbell, Kendall F. Moseley, Steven Hendrickx, Michael Messer et al. · 2024 · Open Forum Infectious Diseases
  50. Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States
    Kathryn Anne Lurain, Talal El Zarif, Ramya Ramaswami, Amin H. Nassar, Elio Adib, Noha Abdel‐Wahab, Nikita Chintapally, Claire E. Drolen, T. A. Feldman, Tarek Haykal et al. · 2024 · Clinical Lymphoma Myeloma & Leukemia
  51. New approaches to design HIV-1 T-cell vaccines
    Hélène Perrin, Glenda Canderan, Rafick‐Pierre Sékaly, Lydie Trautmann · 2010 · Current Opinion in HIV and AIDS
  52. An Interleukin-1 Beta-Encoding Retrovirus Exhibits Enhanced Replication In Vivo
    Edward P. Browne · 2014 · Journal of Virology
  53. Immunosenescence and hurdles in the clinical management of older HIV-patients
    Marco Ripa, Stefania Chiappetta, Giuseppe Tambussi · 2017 · Virulence
  54. Associations of Simian Immunodeficiency Virus (SIV)-Specific Follicular CD8+ T Cells with Other Follicular T Cells Suggest Complex Contributions to SIV Viremia Control
    Mohammad Arif Rahman, Katherine M. McKinnon, Tatiana Karpova, David A. Ball, David J. Venzon, Wenjin Fan, Guobin Kang, Qingsheng Li, Marjorie Robert-Guroff · 2018 · The Journal of Immunology
  55. Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials
    Rachel Bender Ignacio, Lilie L. Lin, Lakshmi N. Rajdev, Elizabeth Y. Chiao · 2018 · Journal of the National Comprehensive Cancer Network
  56. New insights into immune cells cross-talk during IgG4-related disease
    Fahd Touzani, Agnieszka A. Pozdzik · 2018 · Clinical Immunology
  57. A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells
    Torben Knuschke, Sebastian Kollenda, Christina Wenzek, Gennadiy Zelinskyy, Philine Steinbach, Ulf Dittmer, Jan Buer, Matthias Epple, Astrid Maria Westendorf · 2021 · mBio
  58. Pre-existing Simian Immunodeficiency Virus Infection Increases Expression of T Cell Markers Associated with Activation during Early Mycobacterium tuberculosis Coinfection and Impairs TNF Responses in Granulomas
    Erica C. Larson, Amy L. Ellis-Connell, Mark Rodgers, Alexis J. Balgeman, Ryan V. Moriarty, Cassaundra L. Ameel, Tonilynn Baranowski, Jaime A. Tomko, Chelsea M. Causgrove, Pauline A Maiello et al. · 2021 · The Journal of Immunology
  59. Role of statins in regulating molecular pathways following traumatic brain injury: A system pharmacology study
    Ali Asghar Mahmoudi, Sahar Heydari, Yuliya V. Markina, George Emilio Barreto, Amirhossein Sahebkar · 2022 · Biomedicine & Pharmacotherapy
  60. Inhibitory receptor molecules in chronic hepatitis B and C infections: novel targets for immunotherapy?
    Mohamad Saifudin Hakim, Michelle Spaan, Harry L.A. Janssen, André Boonstra · 2013 · Reviews in Medical Virology
  61. Natural course of chronic hepatitis B is characterized by changing patterns of programmed death type-1 of CD8-positive T cells
    Xue-Song Liang · 2010 · World Journal of Gastroenterology
  62. Sanctuaire du virus de l’immunodéficience humaine et mécanismes d’échappement
    Jérôme Estaquier, Bruno Hurtrel · 2008 · médecine/sciences
  63. TCR activation mimics CD127lowPD-1high phenotype and functional alterations of T lymphocytes from septic shock patients
    Julie Mouillaux, Camille Allam, Morgane Gossez, Thomas Uberti, Benjamin Delwarde, Jack Hayman, Thomas R. Rimmele, Julien Textoris, Guillaume Monneret, Estelle Peronnet et al. · 2019 · Critical Care
  64. Anti‐HIV adaptive immunity: determinants for viral persistence
    Hiroyuki Yamamoto, Tetsuro Matano · 2008 · Reviews in Medical Virology
  65. The Immunology of Human Immunodeficiency Virus Infection
    Susan L. Moir, Mark Connors, Anthony S. Fauci · 2015 · Elsevier eBooks
  66. Human Immunodeficiency Virus
    John Guatelli, Robert F. Siliciano, Daniel R. Kuritzkes, Douglas D. Richman · 2016 · ASM Press eBooks
  67. Cannabinoid-Induced Immunomodulation during Viral Infections: A Focus on Mitochondria
    Cherifa Beji, Hamza Loucif, Roman Telittchenko, David P. Olagnier, Xavier Dagenais-Lussier, Julien van Grevenynghe · 2020 · Viruses
  68. Mesenchymal stem cells protect against malaria pathogenesis by reprogramming erythropoiesis in the bone marrow
    Reva Sharan Thakur, Vikky Awasthi, Anirban Sanyal, Samit Chatterjee, Swati Rani, Rubika Chauhan, Meenu Kalkal, Mrinalini Tiwari, Veena Pande, Jyoti Das · 2020 · Cell Death Discovery
  69. Anti-PD-L1 antibody ASC22 in combination with a histone deacetylase inhibitor chidamide as a “shock and kill” strategy for ART-free virological control: a phase II single-arm study
    Luling Wu, Zhihang Zheng, Jingna Xun, Li Liu, Jiangrong Wang, Xinyu Zhang, Yueming Shao, Yinzhong Shen, Renfang Zhang, Min Zhang et al. · 2024 · Signal Transduction and Targeted Therapy
  70. The PD-1/PD-L1 pathway and Epstein–Barr virus
    Hui Wang, Ning Zhang, Rongshuang Xu, Cundong Ji, Youzhen Wei, Zhaoli Liu, Qing Sheng Mi · 2025 · European journal of medical research
  71. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4+ T cell loss rates in human immunodeficiency virus-1 infection
    Frank Olav Pettersen, Kjetil Taskén, Dag Kvale · 2010 · Clinical & Experimental Immunology
  72. Beyond IL-17: new cytokines in the pathogenesis of HIV infection
    Mario Clerici · 2010 · Current Opinion in HIV and AIDS
  73. Macaque Long-Term Nonprogressors Resist Superinfection with Multiple CD8 + T Cell Escape Variants of Simian Immunodeficiency Virus
    Jason T. Weinfurter, Gemma E. May, Taeko Soma, Ann Jones Hessell, Enrique J. León, Caitlin E. MacNair, Shari M. Piaskowski, Kim L. Weisgrau, Jessica R. Furlott, Nicholas J. Maness et al. · 2010 · Journal of Virology
  74. New approaches for the enhancement of chimeric antigen receptors for the treatment of HIV
    Mayra A. Carrillo, Anjie Zhen, Jerome A. Zack, Scott G. Kitchen · 2017 · Translational research
  75. Negative modulation of suppressive HIV-specific regulatory T cells by IL-2 adjuvanted therapeutic vaccine
    Vedran Brezar, Lylia Hani, Mathieu Surénaud, Audrey Hubert, Christine Lacabaratz, Jean‐Daniel Lelièvre, Yves Lévy, Nabila Seddiki · 2017 · PLoS Pathogens
  76. Differential Dynamics of HIV Infection in Humanized MISTRG versus MITRG Mice
    Sandra Ivic, Mary-Aude Rochat, Duo Li, Annette Audigé, Erika Schlaepfer, Christian Münz, Markus Gabriel Manz, Roberto F. Speck · 2017 · ImmunoHorizons
  77. The involvement of plasmacytoid cells in HIV infection and pathogenesis
    Alessandra Aiello, Flavia Giannessi, Zulema Antonia Percario, Elisabetta Affabris · 2018 · Cytokine & Growth Factor Reviews
  78. Immunodeficiency-associated Hodgkin lymphoma
    Antonino Carbone, Annunziata Gloghini, Diego Serraino, Michele Spina, Umberto Tirelli, Emanuela Vaccher · 2021 · Expert Review of Hematology
  79. Impact of Cannabis Use on Immune Cell Populations and the Viral Reservoir in People With HIV on Suppressive Antiretroviral Therapy
    Shane D. Falcinelli, Alicia D. Volkheimer, Lesia Semenova, Ethan Wu, Alexander Richardson, Manickam Ashokkumar, David M. Margolis, Nancie M. Archin, Cynthia D Rudin, David M. Murdoch et al. · 2023 · The Journal of Infectious Diseases
  80. Roles of the programmed cell death 1, T cell immunoglobulin mucin-3, and cluster of differentiation 288 pathways in the low reactivity of invariant natural killer T cells after chronic hepatitis B virus infection
    Zhixin Yang, Lei Yu, Chunbo Chen, Hong Ren, Tongdong Shi · 2015 · Archives of Virology
  81. Transcriptional regulation and T cell exhaustion
    Matthew H. Collins, Andrew J. Henderson · 2014 · Current Opinion in HIV and AIDS
  82. The Inhibitory Co-Receptors: A Way to Save from Anergy the HIVSpecific T Cells
    Rita Simone, Gabriella Piatti, Danièle Saverino · 2009 · Current HIV Research
  83. Cytometry, immunology, and HIV infection: Three decades of strong interactions
    Andrea Cossarizza, Sara De Biasi, Lara Gibellini, Elena Bianchini, Regina Bartolomeo, Milena Nasi, Cristina Mussini, Marcello Pinti · 2013 · Cytometry Part A
  84. T-regulatory cells infected with feline immunodeficiency virus up-regulate programmed death-1 (PD-1)
    Andrea Achleitner, Mary E. Clark, Dorothee Bienzle · 2011 · Veterinary Immunology and Immunopathology
  85. An Altered Maturation and Adhesion Phenotype of Dendritic Cells in Diseased Individuals Compared to Asymptomatic Carriers of Human T Cell Leukemia Virus Type 1
    Sharrón L Manuel, Mohit Sehgal, Zafar K. Khan, James J. Goedert, Michael R. Betts, Pooja Jain · 2013 · AIDS Research and Human Retroviruses
  86. HIV Latency: Present Knowledge and Future Directions
    Xavier Contreras, Tina Lenasi, Boris Matija Peterlin · 2006 · Future Virology
  87. The Programmed Death-1 and Interleukin-10 Pathways Play a Down-Modulatory Role in LP-BM5 Retrovirus-Induced Murine Immunodeficiency Syndrome
    Kathy A. Green, Taku Okazaki, Tasuku Honjo, W. James Cook, William R. Green · 2007 · Journal of Virology
  88. Budigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b study
    Moti N. Ramgopal, Jacob Paul Lalezari, Ana Gabriela Pires dos Santos, Preethi Krishnan, Tanaya R. Vaidya, Fei Zhou, Heide Betman, Patrick K. Dorr, Nael Mohamed Mostafa, Maria Luisa Alcaide et al. · 2025 · Nature Medicine
  89. Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
    Yiru Long, Xiaolu Yu, Runqiu Chen, Yongliang Tong, Likun Gong · 2022 · Frontiers in Immunology
  90. Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV
    Shi Zou, Wei Guo, Songjie Wu, Fangzhao Ming, Yuting Tan, Mengmeng Wu, Weiming Tang, Ke Liang · 2022 · Frontiers in Immunology
  91. Possibility of PD-1/PD-L1 Inhibitors for the Treatment of Patients with Chronic Hepatitis B Infection
    Menghan Su, Ting Ye, Wei Wu, Zheyue Shu, Qi Xia · 2023 · Digestive Diseases
  92. COPD in People with HIV: Epidemiology, Pathogenesis, Management, and Prevention Strategies
    Katerina L. Byanova, Rebecca A. Abelman, Crystal M. North, Stephanie A. Christenson, Laurence Huang · 2023 · International Journal of COPD
  93. Programmed death-1 expression on HIV-1-specific CD8+ T cells is shaped by epitope specificity, T-cell receptor clonotype usage and antigen load
    Henrik N. Kløverpris, Reuben McGregor, James E. McLaren, Kristin Ladell, Anette Stryhn, Catherine Kegakilwe Koofhethile, Jacqui Brener, Fabian Chen, Lynn Riddell, Luzzi Graziano et al. · 2014 · AIDS
  94. Reversal of T-cell exhaustion as a strategy to improve immune control of HIV-1
    John K. Bui, John W. Mellors · 2015 · AIDS
  95. Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining
    Lucas Gonzalez-Nieto, Aline Domingues, Michael J. Ricciardi, Martin J. Gutman, Helen S. Maxwell, Núria Pedreño-López, Varian K. Bailey, Diogo M. Magnani, Maurício A. Martins · 2016 · Journal of Visualized Experiments
  96. Treatment of a patient with HIV and metastatic melanoma with consequitive ipilimumab and nivolumab
    Dirk Tomsitz, R. Hein, Tilo Biedermann, J. Kohlmeyer · 2017 · Journal of the European Academy of Dermatology and Venereology
  97. Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound
    María Rosa López‐Huertas, Carolina Gutiérrez, Nadia Madrid-Elena, Beatriz Hernández‐Novoa, Julián Olalla, Montserrat Plana, Rafael Bastos Delgado, Rafael Rubio, María Ángeles Muñoz‐Fernández, Santiago Moreno · 2020 · Scientific Reports
  98. HIV DNA reservoir and elevated PD‐1 expression of CD4 T‐cell subsets particularly persist in the terminal ileum of HIV‐positive patients despite cART
    Carola Horn, Max Augustin, Meryem Seda Ercanoglu, Eva Heger, Elena Knops, Vincent Bondet, Darragh Duffy, Seung‐Hun Chon, Dirk Nierhoff, Mark Oette et al. · 2021 · HIV Medicine
  99. A Therapeutic Strategy to Combat HIV-1 Latently Infected Cells With a Combination of Latency-Reversing Agents Containing DAG-Lactone PKC Activators
    Kouki Matsuda, Takuya Kobayakawa, Ryusho Kariya, K. Tsuchiya, Shoraku Ryu, Kohei Tsuji, Takahiro M. Ishii, Hiroyuki Gatanaga, Kazuhisa Yoshimura, Seiji Okada et al. · 2021 · Frontiers in Microbiology
  100. Inducible HIV-1 Reservoir Quantification: Clinical Relevance, Applications and Advancements of TILDA
    Cynthia Lungu, Riddhima Banga, Rob A. Gruters, Francesco A. Procopio · 2021 · Frontiers in Microbiology